“Prospective, Single-Center, Phase II Study to Standardize the Mitotane Dosing Regimen in Combination with Platinum-Based Chemotherapy in the First-Line Treatment for Adrenocortical Cancer” (2026) Voprosy onkologii, 72(1), p. OF-2404. doi:10.37469/0507-3758-2026-72-1-OF-2404.